Rescheduling alcohol marketing bans within the World Health Organization menu of policy options.

Addiction

Center for Interdisciplinary Addiction Research (ZIS), Department of Psychiatry and Psychotherapy, University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany.

Published: June 2024

Download full-text PDF

Source
http://dx.doi.org/10.1111/add.16476DOI Listing

Publication Analysis

Top Keywords

rescheduling alcohol
4
alcohol marketing
4
marketing bans
4
bans health
4
health organization
4
organization menu
4
menu policy
4
policy options
4
rescheduling
1
marketing
1

Similar Publications

The rescheduling of cannabis, from the US Drug Enforcement Administration (DEA), current most restrictive (Schedule 1) designation, would be an important step for cannabis research and researchers. We are researchers who have experience with cannabis research in pre-clinical, clinical, and policy domains, who represent a range of social science disciplines (e.g.

View Article and Find Full Text PDF

Background: Codeine-containing compound analgesics (CCCAs) are associated with dependence and, when taken in excess, significant risks of harm. A previous audit showed significant costs related to admissions for gastrointestinal (GI) complications of CCCA. Based on this and other evidence of harm, the Australian Therapeutic Goods Administration changed CCCAs to prescription only in 2018.

View Article and Find Full Text PDF

Introduction: In the United States, dentists frequently prescribe hydrocodone. In October 2014, the US Drug Enforcement Administration rescheduled hydrocodone from controlled substance schedule III to II, introducing more restricted prescribing and dispensing regulations, which may have changed dental prescribing of opioids.

Objective: The study aim was to evaluate the impact of the hydrocodone rescheduling on dental prescribing of opioids in the United States.

View Article and Find Full Text PDF

Aim: To evaluate and document the impacts of re-scheduling codeine to a prescription-only medication in Australia in February 2018.

Design: Prospective cohort study. Participants completed an on-line survey with a range of outcome measures at four time-points, once before codeine was re-scheduled (November 2017) and three times after the event: 1 month after (February 2018), 4 months after (June 2018) and 12 months after (February 2019).

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!